20638 Federal Register / Vol. 63, No. 80 / Monday, April 27, 1998 / Notices

FEDERAL DEPOSIT INSURANCE

CORPORATION

Sunshine Act Meeting; Notice of a

Matter To Be Withdrawn From

Consideration at an Agency Meeting

Pursuant to the provisions of the

‘‘Government in the Sunshine Act’’ (5

U.S.C. 552b), notice is hereby given that

the following matter will be withdrawn

from the ‘‘Discussion Agenda’’ at the

Federal Deposit Insurance Corporation’s

Board of Directors open meeting

scheduled to be held at 10:00 a.m. on

Tuesday, April 28, 1998:

Memorandum re: General Counsel Opinion

Regarding Interest Charges by Interstate State

Banks.

Dated: April 22, 1998.

Federal Deposit Insurance Corporation.

Robert E. Feldman,

Executive Secretary.

[FR Doc. 98–11196 Filed 4–23–98; 8:45 am]

BILLING CODE 6714–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Early Hearing Detection and

Intervention Teleconference meetings

The National Center for

Environmental Health (NCEH) of the

Centers for Disease Control and

Prevention (CDC) announces the

following bi-monthly meetings.

Name: Teleconference meetings of the Ad

Hoc Group for Early Hearing Detection and

Intervention (EHDI).

Times and Dates: 2 p.m.–3 p.m., May 5,

1998; 2 p.m.–3 p.m., July 7, 1998; 2 p.m.–3

p.m., September 1, 1998; 2 p.m.–3 p.m.,

November 3, 1998; 2 p.m.–3 p.m., January 5,

1999’ 2 p.m.–3 p.m., March 2, 1999.

Place: National Center for Environmental

Health, Division of Birth Defects and

Developmental Disabilities, Room 2103A,

Building 101, 4770 Buford Highway, NE,

Atlanta, Georgia 30341, telephone 770/488–

7400.

Status: Open for participation by anyone

with an interest in EHDI. All participants in

the bi-monthly conference calls are, by

definition, members of the Ad Hoc Group for

Early Hearing Detection and Intervention.

Persons wishing to participate must e-mail

(ehdi@cdc.gov) or fax (770/488–7361) their

request. Within one week of each

teleconference, participants will be notified

of the toll-free teleconference phone number,

a caller code and the agenda. Each

participant will have the responsibility to

call in to connect to the conference call.

Purpose: This meeting will provide a

forum for persons associated with EHDI

programs to report and review relevant

activities. Each conference call will be

comprised of a series of scheduled

presentations. Each presentation will be

followed by a brief question and answer

period. The agenda for the conference call

will be determined by the Division of Birth

Defects and Developmental Disabilities in

collaboration with the Office on Disability

and Health, NCEH; the National Institute on

Deafness and Communicative Disorders,

National Institutes of Health; the Bureau of

Maternal and Child Health, Health Resources

and Services Administration; Office of

Special Education and Rehabilitative

Services, Department of Education; and

others interested in early hearing detection

programs. Suggestions and feedback are

invited by the conference call planners.

Participants requesting to be on the agenda

or to make written comments can send their

requests or comments to the e-mail address

or fax numbers noted above.

Matters to be Discussed: Topics to be

discussed during the meetings include

progress on State and National activities to

implement EHDI programs; progress on

establishing State and National data systems

on EHDI; and guidelines for establishing

screening, diagnosis, and intervention

protocols.

Contact Person for More Information: June

Holstrum, Ph.D., Division of Birth Defects

and Developmental Disabilities, NCEH, CDC,

4770 Buford Highway, NE, M/S F–15,

Atlanta, Georgia 30341, telephone 770/488–

7401, e-mail ehdi@cdc.gov, fax 770/488–

7361.

Dated: April 21, 1998.

John C. Burckhardt,

Acting Director, Management Analysis and

Services Office Centers for Disease Control

and Prevention (CDC).

[FR Doc. 98–11065 Filed 4–24–98; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Gastrointestinal Drugs Advisory

Committee; Notice of Meeting

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

This notice announces a forthcoming

meeting of a public advisory committee

of the Food and Drug Administration

(FDA). The meeting will be open to the

public.

Name of Committee: Gastrointestinal

Drugs Advisory Committee.

General Function of the Committee:

To provide advice and

recommendations to the agency on FDA

regulatory issues.

Date and Time: The meeting will be

held on May 28 and 29, 1998, 9 a.m. to

5 p.m.

Location: Holiday Inn, Versailles

Ballrooms I and II, 8120 Wisconsin

Ave., Bethesda, MD.

Contact Person: Joan C. Standaert,

Center for Drug Evaluation and Research

(HFD–110), Food and Drug

Administration, 5600 Fishers Lane,

Rockville MD 20857, 419–259–6211, or

John B. Schupp (HFD–21), 301–443–

5455, or FDA Advisory Committee

Information Line, 1–800–741–8138

(301–443–0572 in the Washington, DC

area), code 12538. Please call the

Information Line for up-to-date

information on this meeting.

Agenda: On May 28, 1998, the

committee will discuss biologics license

application, 98–0012, Centocor, Inc.’s,

AvakineTM (Infliximab), for treatment of

patients with Crohn’s disease. An

indication is sought to: (1) Reduce signs

and symptoms in patients with

moderate to severe disease activity in

whom conventional therapies are

inadequate, and (2) close

entercutaneous fistulas. On May 29,

1998, the committee will hold a general

discussion on guidance for the study of

drugs to treat Crohn’s disease.

Procedure: Interested persons may

present data, information, or views,

orally or in writing, on issues pending

before the committee. Written

submissions may be made to the contact

person by May 21, 1998. Oral

presentations from the public will be

scheduled between approximately 9

a.m. and 10 a.m., on May 28, 1998. Time

allotted for each presentation may be

limited. Those desiring to make formal

oral presentations should notify the

contact person before May 21, 1998, and

submit a brief statement of the general

nature of the evidence or arguments

they wish to present, the names and

addresses of proposed participants, and

an indication of the approximate time

requested to make their presentation.

Notice of this meeting is given under

the Federal Advisory Committee Act (5

U.S.C. app. 2).

Dated: April 17, 1998.

Michael A. Friedman,

Deputy Commissioner for Operations.

[FR Doc. 98–11087 Filed 4–24–98; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF COMMERCE

National Oceanic and Atmospheric

Administration

[I.D. 042098F]

Endangered Species; Permits

AGENCY: National Marine Fisheries

Service (NMFS), National Oceanic and

Atmospheric Administration (NOAA),

Commerce.
Federal Register / Vol. 63, No. 80 / Monday, April 27, 1998 / Notices 20639

ACTION: Notice of receipt of application

for a scientific research permit (1144).

SUMMARY: Notice is hereby given that

Bruce D. Peery, Micheal J. Bresette, and

Jonathan C. Gorham have applied in due

form for a scientific research permit

(1144) to take listed sea turtles.

DATES: Written comments or requests for

a public hearing on this application

must be received on or before May 27,

1998.

ADDRESSES: The application and related

documents are available for review by

appointment in the following offices:

Office of Protected Resources, F/PR3,

NMFS, 1315 East-West Hwy., Room

13307, Silver Spring, MD 20910–3226

(301–713–1401); and

Director, Southeast Region, NMFS,

NOAA, 9721 Executive Center Drive, St.

Petersburg, FL 33702–2432 (813–893–

3141).

Written comments, or requests for a

public hearing on this application

should be submitted to the Chief,

Endangered Species Division, Office of

Protected Resources.

SUPPLEMENTARY INFORMATION: Bruce D.

Peery, Micheal J. Bresette, and Jonathan

C. Gorham request a scientific research

permit under the authority of the

Endangered Species Act of 1973 (ESA)

(16 U.S.C. 1531–1543) and NMFS

regulations governing listed fish and

wildlife permits (50 CFR parts 217–227).

The applicants request a one-year

scientific research permit to take listed

sea turtles. Up to 100 green (Chelonia

mydas) and 50 loggerhead (Caretta

caretta) turtles will be taken in large

mesh tangle nets for the purposes of

assessing the population densities and

dynamics, and to attain growth rates of

sea turtles that utilize the southern

Indian River Lagoon System, Florida.

Captured turtles will be weighed,

photographed, measured, tagged, and

released.

Those individuals requesting a

hearing should set out the specific

reasons why a hearing on this particular

application would be appropriate (see

ADDRESSES). The holding of such

hearing is at the discretion of the

Assistant Administrator for Fisheries,

NOAA. All statements and opinions

contained in this application summary

are those of the applicant and do not

necessarily reflect the views of NMFS.

Dated: April 21, 1998.

Patricia A. Montanio,

Deputy Director, Office of Protected

Resources, National Marine Fisheries Service.

[FR Doc. 98–11018 Filed 4–24–98; 8:45 am]

BILLING CODE 3510–22–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[HCFA–379]

Agency Information Collection

Activities: Proposed Collection;

Comment Request

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, is publishing the

following summary of proposed

collections for public comment.

Interested persons are invited to send

comments regarding the burden

estimate or any other aspect of this

collection of information, including any

of the following subjects: (1) The

necessity and utility of the proposed

information collection for the proper

performance of the agency’s functions;

(2) the accuracy of the estimated

burden; (3) ways to enhance the quality,

utility, and clarity of the information to

be collected; and (4) the use of

automated collection techniques or

other forms of information technology to

minimize the information collection

burden.

Type of Information Collection

Request: Extension of a currently

approved collection; Title of

Information Collection: The Financial

Statement of Debtor and Supporting

regulation 42 CFR 405.376; Form No.:

HCFA–379, OMB #0938–0270; Use: This

form is used to collect financial

information which is needed to evaluate

requests from physician/suppliers to

pay indebtness under extended

repayment schedule, or to compromise

a debt for less than the full amount.

Frequency: As needed; Affected Public:

Business or other for-profit, Not-forprofit institutions; Number of

Respondents: 500; Total Annual

Responses: 500; Total Annual Hours:

1,000.

To obtain copies of the supporting

statement for the proposed paperwork

collections referenced above, or any

related forms, E-mail your request,

including your address and phone

number, to Paperwork@hcfa.gov, or call

the Reports Clearance Office on (410)

786–1326. Written comments and

recommendations for the proposed

information collections must be mailed

within 60 days of this notice directly to

the HCFA Paperwork Clearance Officer

designated at the following address:

HCFA, Office of Information Services,

Information Technology Investment

Management Group, Division of HCFA

Enterprise Standards, Attention: John

Rudolph, Room C2–26–17, 7500

Security Boulevard, Baltimore,

Maryland 21244–1850.

Dated: April 20, 1998.

John P. Burke III,

HCFA Reports Clearance Officer, Division of

HCFA Enterprise Standards, Health Care

Financing Administration.

[FR Doc. 98–11124 Filed 4–24–98; 8:45 am]

BILLING CODE 4120–03–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[HCFA–R–118]

Agency Information Collection

Activities: Submission for OMB

Review; Comment Request

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, has submitted to the

Office of Management and Budget

(OMB) the following proposal for the

collection of information. Interested

persons are invited to send comments

regarding the burden estimate or any

other aspect of this collection of

information, including any of the

following subjects: (1) The necessity and

utility of the proposed information

collection for the proper performance of

the agency’s functions; (2) the accuracy

of the estimated burden; (3) ways to

enhance the quality, utility, and clarity

of the information to be collected; and

(4) the use of automated collection

techniques or other forms of information

technology to minimize the information

collection burden.

Type of Information Collection

Request: Reinstatement without change

of a previously approved collection for

which approval has expired; Title of

Information Collection: Peer Review

Organization Contracts; Solicitation

Statements of Interest from In-State

Organizations, General Notice; Form

No.: HCFA–R–118; Use: This notice is a

solicitation of sources sought for the

procurement of medical review services.

This information is required for

potential contractors to demonstrate that

they meet the statutory requirements as

a Peer Review Organization; Frequency:

On occasion; Affected Public: Business

or other for-profit; Total Annual Hours:

1.

To obtain copies of the supporting

statement for the proposed paperwork

collections referenced above, or E-mail

your request, including your address